# | Title | Journal | Year | Citations |
---|
1 | COVID-19 and African Americans | JAMA - Journal of the American Medical Association | 2020 | 1,609 |
2 | Characteristics, Treatments, and Outcomes of Patients With Preserved Systolic Function Hospitalized for Heart Failure | Journal of the American College of Cardiology | 2007 | 929 |
3 | Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized With Acute Heart Failure | JAMA - Journal of the American Medical Association | 2006 | 854 |
4 | Short-term Clinical Effects of Tolvaptan, an Oral Vasopressin Antagonist, in Patients Hospitalized for Heart FailureThe EVEREST Clinical Status Trials | JAMA - Journal of the American Medical Association | 2007 | 757 |
5 | Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction | Journal of the American College of Cardiology | 2017 | 671 |
6 | Human Aortic Valve Calcification Is Associated With an Osteoblast Phenotype | Circulation | 2003 | 658 |
7 | Estimation of Total Incremental Health Care Costs in Patients With Atrial Fibrillation in the United States | Circulation: Cardiovascular Quality and Outcomes | 2011 | 652 |
8 | Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity | JAMA Cardiology | 2018 | 591 |
9 | Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry | European Heart Journal | 2007 | 514 |
10 | Predictors of In-Hospital Mortality in Patients Hospitalized for Heart Failure | Journal of the American College of Cardiology | 2008 | 506 |
11 | Assessment of Autonomic Function in Cardiovascular Disease | Journal of the American College of Cardiology | 2008 | 450 |
12 | Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina | Circulation Research | 2011 | 433 |
13 | Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study | Heart | 2008 | 382 |
14 | Valve-Related Hemodynamics Mediate Human Bicuspid Aortopathy | Journal of the American College of Cardiology | 2015 | 360 |
15 | Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure | JAMA Cardiology | 2018 | 346 |
16 | Congestion in Acute Heart Failure Syndromes: An Essential Target of Evaluation and Treatment | American Journal of Medicine | 2006 | 339 |
17 | Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design | American Heart Journal | 2004 | 308 |
18 | Gadolinium Cardiovascular Magnetic Resonance Predicts Reversible Myocardial Dysfunction and Remodeling in Patients With Heart Failure Undergoing β-Blocker Therapy | Circulation | 2003 | 307 |
19 | Characterization and Prognostic Value of Persistent Hyponatremia in Patients With Severe Heart Failure in the ESCAPE Trial | Archives of Internal Medicine | 2007 | 300 |
20 | Power Spectral Analysis of Heart Rate Varability in Sudden Cardiac Death: Comparison to Other Methods | IEEE Transactions on Biomedical Engineering | 1986 | 298 |
21 | National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013 | JAMA Cardiology | 2017 | 297 |
22 | Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction | JAMA - Journal of the American Medical Association | 2015 | 288 |
23 | Fluid overload in acute heart failure — Re‐distribution and other mechanisms beyond fluid accumulation | European Journal of Heart Failure | 2008 | 260 |
24 | Relationship of Heart Rate Variability to Parasympathetic Effect | Circulation | 2001 | 255 |
25 | The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF | JACC: Heart Failure | 2018 | 254 |
26 | High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions | Journal of the American College of Cardiology | 2016 | 253 |
27 | Endogenous Sex Hormones and Incident Cardiovascular Disease in Post-Menopausal Women | Journal of the American College of Cardiology | 2018 | 250 |
28 | Demographics, Clinical Characteristics, and Outcomes of Patients Hospitalized for Decompensated Heart Failure: Observations From the IMPACT-HF Registry | Journal of Cardiac Failure | 2005 | 229 |
29 | Usefulness of Red Cell Distribution Width as a Prognostic Marker in Pulmonary Hypertension††Conflicts of interest: Dr. Gomberg-Maitland has received research grant support from Actelion Pharmaceuticals Ltd., Allschwil, Switzerland; CoTherix, Inc., South San Francisco, California; Encysive Pharmaceuticals Inc., Houston, Texas; Gilead Sciences Inc., Foster City, California; Eli Lilly/ICOS, Indianapolis, Indiana; Pfizer Inc., New York, New York; and United Therapeutics, Silver Spring, Maryland. Dr. Gomberg-Mai | American Journal of Cardiology | 2009 | 229 |
30 | Cardiovascular Risk Assessment of the Liver Transplant Candidate | Journal of the American College of Cardiology | 2011 | 223 |
31 | Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population‐based study | Hepatology | 2015 | 221 |
32 | Intravascular ultrasound molecular imaging of atheroma components in vivo | Journal of the American College of Cardiology | 2004 | 218 |
33 | Neurohormonal Inhibition in Heart Failure: Insights from Recent Clinical Trials | American Journal of Cardiology | 2005 | 217 |
34 | Ultrasound lung comets for the differential diagnosis of acute cardiogenic dyspnoea: A comparison with natriuretic peptides☆ | European Journal of Heart Failure | 2008 | 215 |
35 | Prevalence, Clinical Phenotype, and Outcomes Associated With Normal B-Type Natriuretic Peptide Levels in Heart Failure With Preserved Ejection Fraction | American Journal of Cardiology | 2012 | 214 |
36 | Influence of Beta-Blocker Continuation or Withdrawal on Outcomes in Patients Hospitalized With Heart Failure | Journal of the American College of Cardiology | 2008 | 203 |
37 | Left ventricular function during and after right ventricular pacing | Journal of the American College of Cardiology | 2004 | 202 |
38 | Cell Therapy of Peripheral Arterial Disease | Circulation Research | 2013 | 200 |
39 | Cardiac Hemodynamic and Coronary Angiographic Characteristics of Patients Being Evaluated for Liver Transplantation | American Journal of Cardiology | 2006 | 188 |
40 | Recalibrating the Use of Race in Medical Research | JAMA - Journal of the American Medical Association | 2021 | 187 |
41 | Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction | JAMA Cardiology | 2018 | 186 |
42 | Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide | Journal of the American College of Cardiology | 1991 | 185 |
43 | Sudden Cardiac Death Risk Stratification in Patients With Nonischemic Dilated Cardiomyopathy | Journal of the American College of Cardiology | 2014 | 184 |
44 | Stroke Risk as a Function of Atrial Fibrillation Duration and CHA 2 DS 2 -VASc Score | Circulation | 2019 | 178 |
45 | Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery | American Heart Journal | 2012 | 175 |
46 | Acute Hemodynamic Effects of Tolvaptan, a Vasopressin V2 Receptor Blocker, in Patients With Symptomatic Heart Failure and Systolic Dysfunction | Journal of the American College of Cardiology | 2008 | 167 |
47 | Prognostic Importance of Pathophysiologic Markers in Patients With Heart Failure and Preserved Ejection Fraction | Circulation: Heart Failure | 2014 | 166 |
48 | Parasympathetic Effects on Heart Rate Recovery after Exercise | Journal of Investigative Medicine | 2004 | 165 |
49 | Contemporary Use of Digoxin in the Management of Cardiovascular Disorders | Circulation | 2006 | 164 |
50 | Smartwatch Performance for the Detection and Quantification of Atrial Fibrillation | Circulation: Arrhythmia and Electrophysiology | 2019 | 163 |